Evidence map›Paper›PMID 32509344›Full record

ArticleAutoimmune diseases2020

The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients.

Genny Margarita Chaia-Semerena, María Eugenia Vargas-Camaño, Cesar Daniel Alonso-Bello, Jorge Javier Guillén-Toledo, Ricardo Leopoldo Guido-Bayardo, Fernando Lozano-Patiño, Mariano Daniel Temix-Delfín, María Isabel Castrejón-Vázquez

Open access · goldAbstract read
In one paragraph

Article in Autoimmune diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Genny Margarita Chaia-SemerenaClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.
María Eugenia Vargas-CamañoClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.
Cesar Daniel Alonso-BelloClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.ORCID https://orcid.org/0000-0002-5249-2727
Jorge Javier Guillén-ToledoClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.
Ricardo Leopoldo Guido-BayardoClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.
Fernando Lozano-PatiñoClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.
Mariano Daniel Temix-DelfínClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.
María Isabel Castrejón-VázquezClinical Immunology and Allergy Service, National Medical Center 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, México City, Mexico.ORCID https://orcid.org/0000-0002-7556-5810
Institute for Social Security and Services for State Workers · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSeveral studiesdemonstrated that the use of alternate-day corticosteroid therapy maintains control of autoimmune diseases due to the prolongation of their therapeutic effect beyond their metabolic effect, with a significant decrease in side effects in patients. For this reason, the current recommendation for the use of these medications is in a short cycle to avoid adverse effects when used frequently and for prolonged periods of time.

objectivesTo learn variations in serum levels of autoantibodies in autoimmune diseases treated with steroids on alternate days, as well as whether there are differences in the response to them depending on the type of disease.

resultsWe included 106 patients from three autoimmune connective tissue diseases (systemic lupus erythematosus, Sjögren syndrome, and Hashimoto's thyroiditis) and observed a statistically significant decrease in serum autoantibody levels both in patients with lupus and those with Hashimoto's thyroiditis, regardless of the sex of the patients, as well as the type of steroids used.

conclusionsTreatment with alternate-day corticosteroids achieved a statistically significant decrease in serum autoantibody levels in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.

Identifiers

PMID32509344
PMCPMC7251431
OpenAlexW3026189870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.